We searched PubMed for relevant reviews and original articles published during the past 10 years. Search terms were “steroid”, “glucocorticoid”, or “corticosteroid”, and “resistance”. We combined these terms with “asthma”, “COPD”, “ARDS”, “cystic fibrosis”, “rheumatoid arthritis”, “inflammatory bowel disease”, “ulcerative colitis”, Crohn's disease”, and “interstitial pulmonary fibrosis”. Owing to space limitations, we cite recent review articles where possible and do not discuss steroid
ReviewGlucocorticoid resistance in inflammatory diseases
Introduction
Glucocorticosteroids (glucocorticoids; also known as corticosteroids or steroids) are the most effective anti-inflammatory treatments available for many inflammatory and immune diseases, including asthma, rheumatoid arthritis, inflammatory bowel disease, and autoimmune diseases. However, a few patients with these diseases show a poor or absent response even to high doses of glucocorticoids. Other inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), interstitial pulmonary fibrosis, acute respiratory distress syndrome, and cystic fibrosis, seem to be largely glucocorticoid resistant. Since chronic inflammatory diseases are widespread and their prevalence is rising, glucocorticoid resistance or insensitivity represents an important barrier to effective treatment and accounts for substantial health-care spending. We discuss resistance to the anti-inflammatory effects of corticosteroids and the recent identification of several molecular mechanisms of glucocorticoid resistance that might be amenable to new therapeutic approaches.
Section snippets
Glucocorticoid-resistant and insensitive diseases
Although most glucocorticoid resistance studies have focused on asthma, evidence is emerging that similar glucocorticoid resistance is found in many other allergic and chronic inflammatory diseases. The prevalence of glucocorticoid resistance is difficult to measure because of differences in how it is defined and variations over time.
How glucocorticoids suppress inflammation
There have been major advances in the understanding of molecular mechanisms by which glucocorticoids suppress inflammation,40, 41 mainly as a result of research into the proinflammatory and anti-inflammatory genes that they activate and suppress.
Molecular mechanisms of glucocorticoid resistance
Several distinct molecular mechanisms that contribute to decreased anti-inflammatory effects of glucocorticoids have now been identified; there is, then, heterogeneity of mechanisms even within a single disease (panel 1 and figure 4). Similar molecular mechanisms have been identified in different inflammatory diseases, suggesting that common therapeutic approaches might be developed in the future.
Therapeutic implications
There are several therapeutic strategies for management of glucocorticoid-resistant diseases, but the most important general approaches are to use alternative anti-inflammatory (“steroid sparing”) treatments or to reverse the molecular mechanisms of glucocorticoid resistance, if these are known (panel 2). Selective glucocorticoid receptor agonists (SEGRAs; or dissociated steroids) are more effective in transrepression than in transactivation and therefore have few side-effects. However, it is
Reversing glucocorticoid resistance
The most attractive option for treating glucocorticoid resistance is to reverse its cause. For example, this could be achieved by smoking cessation in asthmatic patients who smoke.118 In the future, reversal might be possible for some patients with glucocorticoid-resistant asthma by treatment with p38 MAP kinase inhibitors, JNK inhibitors, and vitamin D3.60, 83, 96 A monoclonal antibody to interleukin-2 receptor (anti-CD25, basiliximab) was found to be clinically effective in patients with
Conclusions
Glucocorticoid resistance is important in several common inflammatory diseases and complicates their clinical management. Many different molecular mechanisms of glucocorticoid resistance have now been elucidated, which might lead to new therapeutic strategies in the future, including the prospect of reversing glucocorticoid resistance.
Search strategy and selection criteria
References (126)
- et al.
Corticosteroid pharmacokinetics in asthma
Lancet
(1990) - et al.
Airway remodeling and lack of bronchodilator response in steroid-resistant asthma
J Allergy Clin Immunol
(2007) - et al.
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
J Allergy Clin Immunol
(2007) - et al.
Cutaneous vasoconstrictor responses to glucocorticoids in asthma
Lancet
(1991) - et al.
Importin alpha: a multipurpose nuclear-transport receptor
Trends Cell Biol
(2004) - et al.
HDAC6 regulates HSP90 acetylation and chaperone-dependent activation of glucocorticoid receptor
Mol Cell
(2005) - et al.
p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma
J Allergy Clin Immunol
(2002) - et al.
Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients
J Allergy Clin Immunol
(2004) - et al.
Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase
J Biol Chem
(2004) - et al.
Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway
J Allergy Clin Immunol
(2004)
Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids
J Biol Chem
Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform
J Allergy Clin Immunol
Quantitative analysis for human glucocorticoid receptor alpha/beta mRNA in IBD
Biochem Biophys Res Commun
Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients
J Allergy Clin Immunol
Cytoskeletal and cell contact control of the glucocorticoid pathway
Mol Cell Endocrinol
Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase
Lancet
Reduced histone deacetylase in COPD: clinical implications
Chest
Oxidative stress reduces histone deacetylase (HDAC)2 activity and enhances IL-8 gene expression: role of tyrosine nitration
Biochem Biophys Res Commun
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy
Gastroenterology
Global strategy for asthma management and prevention: GINA executive summary
Eur Respir J
Glucocorticoid resistance in asthma
Am J Respir Crit Care Med
Steroid resistance in bronchial asthma
Am J Int Med
Corticosteroid resistance in asthma
BMJ
Hereditary glucocorticoid resistance
Ann Endocrinol (Paris)
Hypothalamic-pituitary axis in corticosteroid-resistant asthma
Am J Respir Crit Care Med
Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma
J Exp Med
Asthma and cigarette smoking
Eur Respir J
Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients
Clin Sci
Corticosteroid-resistant chronic asthma and monocyte complement receptors
Clin Exp Immunol
Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A
Am Rev Respir Dis
Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma
Am J Respir Crit Care Med
Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared to non-severe asthma
Thorax
Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives
Rheumatology (Oxford)
Role of mRNA expression of transcription factors in glucocorticoid sensitivity of peripheral blood mononuclear cells and disease state in rheumatoid arthritis
J Rheumatol
The effect of methylprednisolone on proliferation of PBMCs obtained from steroid-sensitive and steroid-resistant rheumatoid arthritis patients
Scand J Rheumatol
Glucocorticoid resistance in inflammatory bowel disease
J Endocrinol
Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes
Gut
Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus
Arthritis Rheum
Superantigens, steroid insensitivity and innate immunity in atopic eczema
Acta Derm Venereol Suppl (Stockh)
Inhaled corticosteroids for stable chronic obstructive pulmonary disease
Cochrane Database Syst Rev
Methodological issues in therapeutic trials of COPD
Eur Respir J
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
Am J Respir Crit Care Med
Effect of high dose inhaled steroid on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease
Am J Respir Crit Care Med
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial
Thorax
Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease
Am J Respir Crit Care Med
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease
Am J Respir Crit Care Med
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease
Thorax
Immunology of asthma and chronic obstructive pulmonary disease
Nat Immunol Rev
Inhaled corticosteroids for cystic fibrosis
Cochrane Database Syst Rev
Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?
Eur J Pediatr
Cited by (828)
Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug delivery
2023, Journal of Controlled ReleaseModulation of inflammatory and oxidative stress biomarkers due to dexamethasone exposure in chicken splenocytes
2023, Veterinary Immunology and ImmunopathologyIsochlorogenic acid A alleviates dextran sulfate sodium-induced ulcerative colitis in mice through STAT3/NF-кB pathway
2023, International ImmunopharmacologyBlockade of neutrophil extracellular traps ameliorates toluene diisocyanate-induced steroid-resistant asthma
2023, International Immunopharmacology